Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Edoxaban tablets versus LIXIANA in healthy Thai adults under fasting conditions
TCTR20260814003Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of edoxaban in thromboembolism (2 arms), sponsored by Bio-innova. Primary endpoints: Maximum plasma concentration, Area under the plasma concentration-time curve to last observed concentration and 1 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
edoxaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on TCTR20260814003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260814003.